| Policy Title | Policy Number | Effective Date |
|---|
| Abaloparatide (Tymlos) (PDF) | CP.PHAR.345 | October 1, 2025 |
| Abatacept (Orencia) (PDF) | CP.PHAR.241 | July 1, 2024 |
| Abemaciclib (Verzenio) (PDF) | CP.PHAR.355 | January 1, 2025 |
| Abiraterone (Zytiga) (PDF) | CP.PHAR.84 | April 1, 2025 |
| AbobotulinumtoxinA (Dysport) (PDF) | CP.PHAR.230 | October 1, 2025 |
| Abrocitinib (Cibinqo) (PDF) | CP.PHAR.578 | October 1, 2025 |
| Acalabrutinib (Calquence) (PDF) | CP.PHAR.366 | June 1, 2025 |
| Acoltremon (Tryptyr) (PDF) | CP.PHAR.739 | October 1, 2025 |
| Acoramidis (Attruby) (PDF) | CP.PHAR.683 | October 1, 2025 |
| Acyclovir Buccal tab (Sitavig) (PDF) | CP.PMN.210 | January 1, 2025 |
| Adagrasib (Krazati) (PDF) | CP.PHAR.605 | October 1, 2025 |
| Adagrasib (Krazati) (PDF) | CP.PHAR.605 | Version effective until October 1, 2025 |
| ADAMTS13, recombinant-krhn (Adzynma) (PDF) | CP.PHAR.635 | April 1, 2025 |
| Adefovir (Hepsera) (PDF) | CP.PHAR.142 | January 1, 2025 |
| Ado-Trastuzumab Emtansine (Kadcyla) (PDF) | CP.PHAR.229 | July 1, 2025 |
| Aducanumab (Aduhelm) (PDF) | CP.PHAR.468 | July 1, 2025 |
| Afamelanotide (Scenesse) (PDF) | CP.PHAR.444 | April 1, 2025 |
| Afamitresgene Autoleucel (Tecelra) (PDF) | CP.PHAR.678 | May 1, 2025 |
| Afatinib (Gilotrif) (PDF) | CP.PHAR.298 | July 1, 2025 |
| Aflibercept (Eylea, Eylea HD, Opuviz, Yesafili, Ahzantive, Enzeevu, Pavblu) (PDF) | CP.PHAR.184 | August 1, 2025 |
| Agalsidase Beta (Fabrazyme) (PDF) | CP.PHAR.158 | September 1, 2025 |
| Agalsidase Beta (Fabrazyme) (PDF) | CP.PHAR.158 | September 1, 2025 |
| Age Limit Override (Codeine, Tramadol, Hydrocodone) (PDF) | CP.PMN.138 | October 1, 2025 |
| Alectinib (Alecensa) (PDF) | CP.PHAR.369 | July 1, 2025 |
| Alemtuzumab (Lemtrada) (PDF) | CP.PHAR.243 | July 1, 2025 |
| Alendronate (Binosto, Fosamax plus D) (PDF) | CP.PMN.88 | April 1, 2025 |
| Alglucosidase (Lumizyme) (PDF) | CP.PHAR.160 | April 1, 2025 |
| Allogeneic cultured keratinocytes and dermal fibroblasts (StrataGraft) (PDF) | CP.PHAR.562 | April 1, 2025 |
| Allogenic processed thymus tissue-agdc (Rethymic) (PDF) | CP.PHAR.563 | April 1, 2025 |
| Alpelisib (Piqray) (PDF) | CP.PHAR.430 | December 1, 2025 |
| Alpha-1 Proteinase Inhibitors (Aralast® NP, Glassia®, Prolastin-C®, Zemaira®) (PDF) | CP.PHAR.94 | April 1, 2025 |
| Amantadine ER (Gocovri,Osmolex ER) (PDF) | CP.PMN.89 | April 1, 2025 |
| Ambrisentan (Letairis®) (PDF) | CP.PHAR.190 | April 1, 2025 |
| Amifampridine (Firdapse)(PDF) | CP.PHAR.411 | April 1, 2025 |
| Amikacin (Arikayce)(PDF) | CP.PHAR.401 | October 1, 2025 |
| Amisulpride (Barhemsys)(PDF) | CP.PMN.236 | October 1, 2025 |
| Amivantamab-vmjw (Rybrevant) (PDF) | CP.PHAR.544 | December 1, 2025 |
| Anifrolumab-fnia (Saphnelo) (PDF) | CP.PHAR.551 | March 1, 2025 |
| Anti-Inhibitor Coagulant Complex, Human (Feiba) (PDF) | CP.PHAR.217 | April 1, 2025 |
| Antithymocyte Globulin (Thymoglobulin, Atgam) (PDF) | CP.PHAR.506 | January 1, 2025 |
| Antithrombin III (ATryn, Thrombate III) (PDF) | CP.PHAR.564 | April 1, 2025 |
| Apalutamide (Erleada) (PDF) | CP.PCH.45 | July 1, 2025 |
| Apomorphine (Apokyn) (PDF) | CP.PHAR.488 | October 1, 2025 |
| Aprepitant (Emend®) (PDF) | CP.PMN.19 | October 1, 2025 |
| Aprocitentan (Tryvio) (PDF) | CP.PHAR.676 | July 1, 2025 |
| Aripiprazole Long-Acting Injections (Abilify Maintena, Aristada) (PDF) | CP.PHAR.290 | October 1, 2025 |
| Aripiprazole ODT (Abilify) (PDF) | CP.PMN.300 | April 1, 2025 |
| Armodafinil (Nuvigil) (PDF) | CP.PMN.35 | July 1, 2025 |
| Asciminib (Scemblix) (PDF) | CP.PHAR.565 | June 1, 2025 |
| Asenapine (Saphris) (PDF) | CP.PMN.15 | October 1, 2025 |
| Asfotase Alfa (Strensiq) (PDF) | CP.PHAR.328 | January 1, 2025
|
| Aspirin-dipyridamole (Aggrenox) (PDF) | CP.PMN.20 | April 1, 2025 |
| Atezolizumab (Tecentriq) (PDF) | CP.PHAR.235 | June 1, 2025
|
| Atidarsagene autotemcel (Lenmeldy) (PDF) | CP.PHAR.602 | August 1, 2025 |
| Atogepant (Qulipta) (PDF) | CP.PHAR.566 | March 1, 2025 |
| Atrasentan (Vanrafia) (PDF) | CP.PHAR.727 | July 1, 2025 |
| Avacopan (Tavneos) (PDF) | CP.PHAR.515 | April 1, 2025 |
| Avacincaptad pegol (Izervay) (PDF) | CP.PHAR.641 | May 1, 2025 |
| Avalglucosidase alfa-ngpt (Nexviazyme) (PDF) | CP.PHAR.521 | April 1, 2025 |
| Avapritinib (Ayvakit) (PDF) | CP.PHAR.454 | April 1, 2025 |
| Avatrombopag (Doptelet) (PDF) | CP.PHAR.130 | March 1, 2025 |
| Avelumab (Bavencio) (PDF) | CP.PHAR.333 | April 1, 2025 |
| Avutometinib, Defactinib (Avmapki Fakzynja Co-Pack) (PDF) | CP.PHAR.731 | October 1, 2025 |
| Axatilimab-csfr (Niktimvo) (PDF) | CP.PHAR.691 | April 1, 2025 |
| axicabtagene ciloleucel (Yescarta®) (PDF) | CP.PHAR.362 | June 1, 2025 |
| Axitinib (Inlyta) (PDF) | CP.PHAR.100 | April 1, 2025 |
| Azacitidine (Vidaza) (PDF) | CP.PHAR.387 | March 1, 2025 |
| Azelaic Acid (Finacea) (PDF) | HIM.PA.119 | January 1, 2025 |
| Aztreonam (Cayston) (PDF) | CP.PHAR.209 | October 1, 2025 |
| Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) | CP.PHAR.149 | January 1, 2025 |
| Baloxavir Marboxil (Xofluza) (PDF) | CP.PMN.185 | January 1, 2025 |
| Bamlanivimab-etesevimab (LY-CoV555-LY-CoV016) (PDF) | CP.PHAR.532 | July 1, 2023 |
| Bardoxolone Methyl (RTA 402) (PDF) | CP.PHAR.560 | December 1, 2023 |
| Bedaquiline (Sirturo) (PDF) | CP.PMN.212 | April 1, 2025 |
| Belatacept (Nulojix®) (PDF) | CP.PHAR.201 | January 1, 2025 |
| Belimumab (Benlysta) (PDF) | CP.PHAR.88 | October 1, 2025 |
| Belinostat (Beleodaq®) (PDF) | CP.PHAR.311 | March 1, 2025 |
| Bempedoic acid (Nexletol), bempedoic acid-ezetimibe (Nexlizet) (PDF) | CP.PMN.237 | April 1, 2025 |
| Bendamustine (Bendeka®, Treanda®) (PDF) | CP.PHAR.307 | March 1, 2025 |
| Benralizumab (Fasenra) (PDF) | HIM.PA.SP70 | March 1, 2025 |
| Benralizumab (Fasenra) (PDF) | CP.PHAR.373 | January 1, 2025 |
| Benznidazole (PDF) | CP.PMN.90 | April 1, 2025 |
| Berdazimer (Zelsuvmi) (PDF) | CP.PMN.293 | July 1, 2025 |
| Beremagene Geperpavec (Vyjuvek) (PDF) | CP.PHAR.592 | December 1, 2025 |
| Betaine (Cystadane) (PDF) | CP.PHAR.143 | March 1, 2025 |
| Betibeglogene autotemcel (PDF) | CP.PHAR.545 | October 1, 2024 |
| Bevacizumab (Alymsys, Avastin, Avzivi, Mvasi, Vegzelma, Zirabev) (PDF) | CP.PHAR.93 | September 1, 2025 |
| Bexarotene (Targretin) (PDF) | CP.PHAR.75 | July 1, 2025 |
| Bezlotoxumab (Zinplava) (PDF) | CP.PHAR.300 | April 1, 2025 |
| Belantamab mafodotin (Blenrep) (PDF) | CP.PHAR.469 | July 1, 2025 |
| Belumosudil (Rezurock) (PDF) | CP.PHAR.552 | January 1, 2025 |
| Belzutifan (Welireg) (PDF) | CP.PHAR.553 | September 1, 2025 |
| Berotralstat (Orladeyo) (PDF) | HIM.PA.169 | October 1, 2025 |
| Betamethasone Dipropionate Spray (Sernivo) (PDF) | CP.PMN.182 | January 1, 2025 |
| Bimatoprost Implant (Durysta) (PDF) | CP.PHAR.486 | October 1, 2025 |
| Binimetinib (Mektovi) (PDF) | CP.PHAR.50 | July 1, 2025 |
| Biologic and Non-biologic DMARDs (PDF) | HIM.PA.SP60 | October 1, 2025 |
| Birch Triterpenes (Filsuvez) (PDF) | CP.PHAR.669 | June 1, 2025 |
| Blinatumomab (Blincyto) (PDF) | CP.PHAR.312 | December 1, 2025 |
| Bortezomib (Velcade) (PDF) | CP.PHAR.410 | April 1, 2025 |
| Bosentan (Tracleer®) (PDF) | CP.PHAR.191 | April 1, 2025 |
| Bosutinib (Bosulif) (PDF) | CP.PHAR.105 | July 1, 2025 |
| Brand Name Override and Non-Formulary Medications (PDF) | HIM.PA.103 | August 1, 2025 |
| Brentuximab Vedotin (Adcetris) (PDF) | CP.PHAR.303 | December 1, 2025 |
| Brexanolone (Zulresso) (PDF) | CP.PHAR.417 | July 1, 2025 |
| Brexpiprazole (Rexulti) (PDF) | CP.PMN.68 | October 1, 2025 |
| Brexucabtagene Autoleucel (Tecartus) (PDF) | CP.PHAR.472 | April 1, 2025 |
| Brigatinib (Alunbrig) (PDF) | CP.PHAR.342 | July 1, 2025 |
| Brivaracetam (Briviact) (PDF) | CP.PMN.297 | January 1, 2025 |
| Brolucizumab-dbll (Beovu) (PDF) | CP.PHAR.445 | June 1, 2025 |
| Brimonidine (Mirvaso) (PDF) | CP.PMN.192 | October 1, 2025 |
| Brimonidine (Mirvaso) (PDF) | CP.PMN.192 | Version effective until October 1, 2025 |
| Brinzolamide/Brimonidine (Simbrinza) (PDF) | HIM.PA.15 | January 1, 2025 |
| Brivaracetam (Briviact) (PDF) | CP.PCH.26 | January 1, 2025 |
| Budesonide (Eohilia, Uceris) (PDF) | CP.PMN.294 | July 1, 2025 |
| Budesonide (Tarpeyo) (PDF) | CP.PHAR.572 | April 1, 2025 |
| Buprenorphine/Naloxone (Bunavail, Cassipa, Suboxone, Zubsolv) (PDF) | CP.PMN.81 | April 1, 2025 |
| Buprenorphine (Subutex) | CP.PMN.82 | April 1, 2025 |
| Butorphanol Nasal Spray (PDF) | HIM.PA.46 | July 1, 2025 |
| C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (PDF) | HIM.PA.170 | October 1, 2025 |
| Cabazitaxel (Jevtana) (PDF) | CP.PHAR.316 | July 1, 2025 |
| Cabotegravir, Cabotegravir-Rilpivirine (Apretude Cabenuva) (PDF) | CP.PHAR.573 | April 1, 2025 |
| Cabozantinib (Cometriq®, Cabometyx®) (PDF) | CP.PHAR.111 | December 1, 2025 |
| Calcifediol (Rayaldee) (PDF) | CP.PMN.76 | October 1, 2025 |
| Calcipotriene/Betamethasone Dipropionate Foam (Enstilar) (PDF) | CP.PMN.181 | January 1, 2025 |
| Canakinumab (Ilaris) (PDF) | CP.PHAR.246 | October 1, 2025 |
| Cannabidiol (Epidiolex) (PDF) | CP.PMN.164 | October 1, 2025 |
| Capecitabine (Xeloda) (PDF) | CP.PHAR.60 | July 1, 2025 |
| Capivasertib (Truqap) (PDF) | CP.PHAR.663 | April 1, 2025 |
| Caplacizumab-yhdp (Cablivi) (PDF) | CP.PHAR.416 | July 1, 2025 |
| Capmatinib (Tabrecta) (PDF) | CP.PHAR.494 | October 1, 2025 |
| Carbetocin (PDF) | CP.PHAR.546 | Pending FDA Approval |
| Carbidopa-Levodopa ER Capsules (Rytary), Enteral Suspension (Duopa) (PDF) | CP.PMN.238 | October 1, 2025 |
| Carfilzomib (Kyprolis®) (PDF) | CP.PHAR.309 | March 1, 2025 |
| Carglumic acid (Carbaglu®) (PDF) | CP.PHAR.206 | June 1, 2025 |
| Cariprazine (Vraylar) (PDF) | CP.PMN.91 | October 1, 2025 |
| Casimersen (Amondys 45) (PDF) | CP.PHAR.470 | April 1, 2025 |
| Casirivimab and imdevimab (REGEN-COV) (PDF) | CP.PHAR.520 | July 1, 2023 |
| Celecoxib (Celebrex) (PDF) | CP.PMN.122 | December 1, 2023 |
| Cemiplimab-rwlc (Libtayo) (PDF) | CP.PHAR.397 | January 1, 2025 |
| Cenegermin-bkbj (Oxervate)(PDF) | CP.PMN.186 | April 1, 2025 |
| Cenobamate (Xcopri) (PDF) | CP.PMN.231 | April 1, 2025 |
| Ceritinib (Zykadia) (PDF) | CP.PHAR.349 | September 1, 2025 |
| Cerliponase alfa (Brineura) (PDF) | CP.PHAR.338 | October 1, 2025 |
| Cetuximab (Erbitux®) (PDF) | CP.PHAR.317 | March 1, 2025 |
| Chenodiol (Chenodal) (PDF) | CP.PMN.239 | December 1, 2025 |
| Chlorambucil (Leukeran) (PDF) | CP.PHAR.554 | March 1, 2025 |
| Chloramphenicol Sodium Succinate (PDF) | CP.PHAR.388 | October 1, 2025 |
| Cholic Acid (Cholbam) (PDF) | CP.PHAR.390 | January 1, 2025 |
| Ciclopirox (Penlac) (PDF) | CP.PMN.24 | April 1, 2025 |
| Ciltacabtagene Autoleucel (Carvykti) (PDF) | CP.PHAR.533 | July 1, 2025 |
| Cinacalcet (Sensipar) (PDF) | CP.PHAR.61 | December 1, 2025 |
| Cipaglucosidase Alfa-atga + Miglustat (Pombiliti + Opfolda) (PDF) | CP.PHAR.567 | April 1, 2025 |
| Ciprofloxacin-Dexamethasone (Ciprodex) (PDF) | CP.PMN.248 | January 1, 2025 |
| Ciprofloxacin/Fluocinolone (Otovel) (PDF) | CP.PMN.249 | January 1, 2025 |
| Cladribine (Mavenclad) (PDF) | CP.PHAR.422 | October 1, 2025 |
| Clascoterone (Winlevi) (PDF) | CP.PMN.257 | April 1, 2025 |
| Clesrovimab-cfor (Enflonsia) (PDF) | CP.PHAR.740 | October 1, 2025 |
| Clobazam (Onfi) (PDF) | CP.PMN.54 | January 1, 2025 |
| CNS Stimulants (PDF) | CP.PMN.92 | June 1, 2025 |
| Cobimetinib (Cotellic) (PDF) | CP.PHAR.380 | July 1, 2025 |
| Colchicine (Colcrys, Lodoco) (PDF) | CP.PMN.123 | April 1, 2025 |
| Colesevelam (Welchol) (PDF) | CP.PMN.250 | January 1, 2025 |
| Collagenase (Xiaflex) (PDF) | CP.PHAR.82 | October 1, 2025 |
| Colonoscopy Preparation Products (PDF) | CP.PCH.43 | January 1, 2025 |
| Compounded Medications (PDF) | CP.PMN.280 | October 1, 2025 |
| Concizumab (NN7415) (PDF) | CP.PHAR.625 | September 1, 2025 |
| Conjugated Estrogens/Bazedoxifene (Duavee) (PDF) | CP.PMN.258 | April 1, 2025 |
| Continuous Glucose Monitors (PDF) | CP.PMN.214 | August 1, 2025 |
| Copanlisib (Aliqopa®) (PDF) | CP.PHAR.357 | March 1, 2025 |
| Corticosteroid Intravitreal Implants (Iluvien, Ozurdex, Retisert, Yutiq) (PDF) | CP.PHAR.385 | October 1, 2025 |
| Corticotropin (H.P. Acthar, Purified Cortrophin Gel) (PDF) | HIM.PA.168 | October 1, 2025 |
| Cosibelimab-Ipdl (Unloxcyt) (PDF) | CP.PHAR.711 | August 1, 2025 |
| Cosyntropin (Cortrosyn) (PDF) | CP.PHAR.203 | June 1, 2025 |
| Crinecerfont (Crenessity) (PDF) | CP.PHAR.692 | April 1, 2025 |
| Crisaborole (Eucrisa) (PDF) | CP.PMN.110 | July 1, 2025 |
| Crizanlizumab-tmca (Adakveo) (PDF) | CP.PHAR.449 | October 1, 2025 |
| Crizotinib (Xalkori) (PDF) | CP.PHAR.90 | July 1, 2025 |
| Crovalimab (PDF) | CP.PHAR.664 | October 1, 2025 |
| Cyclosporine (Cequa, Restasis, Verkazia, Vevye, Klarity-C) (PDF) | CP.PMN.48 | October 1, 2025 |
| Cysteamine Ophthalmic (Cystaran, Cystadrops) (PDF) | CP.PMN.130 | July 1, 2025 |
| Cysteamine oral (Cystagon, Procysbi) (PDF) | CP.PHAR.155 | October 1, 2025 |
| Cytomegalovirus Immune Globulin (Cytogam) (PDF) | CP.PHAR.277 | October 1, 2025 |
| Dabrafenib (Tafinlar) (PDF) | CP.PHAR.239 | July 1, 2025 |
| Dacomitinib (Vizimpro) (PDF) | CP.PHAR.399 | January 1, 2025 |
| Dalfampridine (Ampyra) (PDF) | CP.PHAR.248 | July 1, 2025 |
| Dalteparin (Fragmin) (PDF) | CP.PHAR.225 | April 1, 2025 |
| Danicopan (ALXN2040) (PDF) | CP.PHAR.665 | December1, 2025 |
| Daprodustat (Jesduvroq) (PDF) | CP.PHAR.628 | July 1, 2025 |
| Daptomycin (Cubicin, Cubicin RF) (PDF) | CP.PHAR.351 | October 1, 2025 |
| Dapsone (Aczone Gel) (PDF) | CP.PCH.32 | March 1, 2025 |
| Daratumumab (Darzalex) (PDF) | CP.PHAR.310 | October 1, 2025 |
| Darbepoetin alfa (Aranesp) (PDF) | CP.PHAR.236 | September 1, 2025 |
| Darolutamide (Nubeqa) (PDF) | CP.PHAR.435 | October 1, 2025 |
| Dasabuvir-Ombitasvir-Paritaprevir-Ritonavir (Viekira Pak) (PDF) | HIM.PA.SP61 | October 1, 2025 |
| Dasatinib (Sprycel, Phyrago) (PDF) | CP.PHAR.72 | October 1, 2025 |
| Dasiclucagon (ZP4207) (PDF) | CP.PHAR.642 | December 1, 2023 |
| Datopotamab Deruxtecan-dlnk (Datroway) (PDF) | CP.PHAR.715 | October 1, 2025 |
| DaxibotulinumtoxinA-lanm (Daxxify) (PDF) | CP.PHAR.651 | January 1, 2025 |
| Daunorubicin/cytarabine (Vyxeos®) (PDF) | CP.PHAR.352 | January 1, 2025 |
| Decitabine-Cedazuridine (Inqovi) (PDF) | CP.PHAR.479 | October 1, 2025 |
| Deferasirox (Exjade Jadenu) (PDF) | CP.PHAR.145 | December 1, 2025 |
| Deferiprone (Ferriprox) (PDF) | CP.PHAR.147 | December 1, 2025 |
| Deferoxamine (Desferal) (PDF) | CP.PHAR.146 | December 1, 2025 |
| Deflazacort (Emflaza) (PDF) | CP.PHAR.331 | April 1, 2025 |
| Degarelix Acetate (Firmagon) (PDF) | CP.PHAR.170 | January 1, 2025 |
| Delafloxacin (Baxdela) (PDF) | CP.PMN.115 | October 1, 2025 |
| Delandistrogene moxeparvovec-rokl (Elevidys) (PDF) | CP.PCH.56 | October 1, 2025 |
| Denileukin Diftitox-cxdl (Lymphir) (PDF) | CP.PHAR.693 | May 1, 2025 |
| Denosumab (Prolia, Xgeva and biosimilars) (PDF) | CP.PHAR.58 | July 1, 2025 |
| Desmopressin Acetate (DDAVP, Stimate, Noctiva) (PDF) | CP.PHAR.214 | June 1, 2025 |
| Deutetrabenazine (Austedo, Austedo XR) (PDF) | CP.PCH.42 | July 1, 2025 |
| Dexrazoxane (Zinecard, Totect) (PDF) | CP.PHAR.418 | September 1, 2025 |
| Dextromethorphan-bupropion (Auvelity) (PDF) | CP.PMN.284 | January 1, 2025 |
| Dextromethorphan-Quinidine (Nuedexta) (PDF) | CP.PMN.93 | April 1, 2025 |
| Diazepam Nasal Spray (Libervant, Valtoco)(PDF) | CP.PMN.216 | July 1, 2025 |
| Diazoxide Choline (Vykat XR) (PDF) | CP.PHAR.701 | July 1, 2025 |
| Dichlorphenamide (Keveyis) (PDF) | CP.PMN.261 | April 1, 2025 |
| Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex) (PDF) | CP.PCH.28 | January 1, 2025 |
| DimethylFumarate (Tecfidera), Diroximel Fumarate (Vumerity), Monomethyl Fumarate (Bafiertam) (PDF) | CP.PHAR.249 | October 1, 2025 |
| Enfuvirtide (Fuzeon) (PDF) | CP.PHAR.41 | October 1, 2025 |
| Dipeptidyl Peptidase-4 Inhibitors (PDF) | HIM.PA.58 | May 1, 2025 |
| Dolasetron (Anzemet) (PDF) | CP.PMN.141 | October 1, 2025 |
| Donanemab-azbt (Kinsunla) (PDF) | CP.PHAR.594 | March 1, 2025 |
| Donislecel (Lantidra) (PDF) | CP.PHAR.569 | December 1, 2023 |
| Dornase alfa (Pulmozyme) (PDF) | CP.PHAR.212 | October 1, 2025 |
| Dostarlimab-gxly (Jemperli) (PDF) | CP.PHAR.540 | October 1, 2025 |
| Doxepin Hydrochloride Cream (Prudoxin, Zonalon) (PDF) | HIM.PA.147 | January 1, 2025 |
| Doxycycline Hyclate (Acticlate, Doryx), Doxycycline (Oracea) (PDF) | CP.PMN.79 | October 1, 2025 |
| Dupilumab (Dupixent) (PDF) | HIM.PA.SP69 | August 1, 2025 |
| Durvalumab (Imfinzi) (PDF) | CP.PHAR.339 | September 1, 2025 |
| Dutasteride (Avodart), Dutasteride/Tamsulosin (Jalyn) (PDF) | CP.PMN.128 | July 1, 2025 |
| Duvelisib (Copiktra) (PDF) | CP.PHAR.400 | March 1, 2025 |
| Ecallantide (Kalbitor) (PDF) | CP.PHAR.177 | October 1, 2025 |
| Eculizumab (Soliris) (PDF) | CP.PHAR.97 | December 1, 2025
|
| Edaravone (Radicava, Radivaca ORS) (PDF) | CP.PHAR.343 | September 1, 2025 |
| Efgartigimod alfa, efgartigimod-hyaluronidase (Vyvgart, Vyvgart Hytrulo) (PDF) | CP.PHAR.555
| July 1, 2025 |
| Efinaconazole (Jublia) (PDF) | CP.PMN.25 | April 1, 2025 |
| Eflornithine (Iwilfin) (PDF) | CP.PHAR.670 | April 1, 2025 |
| Elacestrant (Orserdu) (PDF) | CP.PHAR.623 | September 1, 2025 |
| Eladocagene Exuparvovec-tneq (Kebilidi) (PDF) | CP.PHAR.595 | May 1, 2025 |
| Elagolix (Orilissa), elagolix-estradiol-norethindrone (Oriahnn) (PDF) | CP.PHAR.136 | March 1, 2025 |
| Elapegademase-lvlr (Revcovi) (PDF) | CP.PHAR.419 | July 1, 2025 |
| Elbasvir/Grazoprevir (Zepatier) (PDF) | HIM.PA.SP62 | December 1, 2025 |
| Elafibranor (Iqirvo) (PDF) | CP.PHAR.688 | October 1, 2025 |
| Eliglustat (Cerdelga) (PDF) | CP.PHAR.153 | July 1, 2025 |
| Elexacaftor-ivacaftor-tezacaftor (Trikafta) (PDF) | CP.PHAR.440 | October 1, 2025 |
| Elosulfase Alfa (Vimizim) (PDF) | CP.PHAR.162 | July 1, 2025 |
| Elotuzumab (Empliciti) (PDF) | CP.PHAR.308 | March 1, 2025 |
| Elranatamab-bcmm (Elrexfio) (PDF) | CP.PHAR.652 | January 1, 2025 |
| Eltrombopag (Promacta®) (PDF) | CP.PHAR.180 | April 1, 2025 |
| Eluxadoline (Viberzi) (PDF) | CP.PMN.170 | January 1, 2025 |
| Elivaldogene Autotemcel (PDF) | CP.PHAR.556 | January 1, 2025 |
| Emapalumab-lzsg (Gamifant)(PDF) | CP.PHAR.402 | October 1, 2025 |
| Emicizumab-kxwh (Hemlibra) (PDF) | CP.PHAR.370 | April 1, 2025 |
| Emtricitabine/Tenofovir Alafenamide (Descovy) (PDF) | CP.PMN.235 | July 1, 2025 |
| Enasidenib (Idhifa) (PDF) | CP.PHAR.363 | January 1, 2025 |
| Encorafenib (Braftovi) (PDF) | CP.PHAR.127 | July 1, 2025 |
| Enfuvirtide (Fuzeon) (PDF) | CP.PHAR.41 | July 1, 2021 |
| Enfortumab Vedotin-ejfv (Padcev) (PDF) | CP.PHAR.455 | April 1, 2025 |
| Enoxaparin (Lovenox) (PDF) | CP.PHAR.224 | April 1, 2025 |
| Ensartinib (Ensacove) (PDF) | CP.PHAR.712 | April 1, 2025 |
| Entecavir (Baraclude) (PDF) | HIM.PA.08 | July 1, 2025 |
| Entrectinib (Rozlytrek) (PDF) | CP.PHAR.441 | March 1, 2025 |
| Enzalutamide (Xtandi) (PDF) | CP.PHAR.106 | April 1, 2025 |
| Enzalutamide (Xtandi) (PDF) | HIM.PA.164 | May 1, 2023 |
| Epinephrine (Epipen, Epipen Jr, Neffy, Auvi-Q) (PDF) | CP.PCH.55 | December 1, 2025 |
| Epcoritamab-bysp (Epkinly) (PDF) | CP.PHAR.634 | October 1, 2025 |
| Eplontersen (Wainua) (PDF) | CP.PHAR.633 | July 1, 2025 |
| Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (PDF) | CP.PHAR.237 | August 1, 2025 |
| Epoprostenol (PDF) | CP.PHAR.192 | April 1, 2025 |
| Eptinezumab-jjmr (Vyepti) (PDF) | HIM.PA.SP64 | March 1, 2025 |
| Erdafitinib (Balversa) (PDF) | CP.PHAR.423 | October 1, 2025 |
| Erenumab-aaoe (Aimovig) (PDF) | HIM.PA.SP65 | March 1, 2025 |
| Eribulin Mesylate (Halaven®) (PDF) | CP.PHAR.318 | January 1, 2025 |
| Erlotinib (Tarceva) (PDF) | CP.PHAR.74 | July 1, 2025 |
| Erwinia Asparaginase (Erwinaze) (PDF) | CP.PHAR.301 | April 1, 2025 |
| Esketamine (Spravato) (PDF) | CP.PMN.199 | July 1, 2025 |
| Estradiol Vaginal Ring (Femring) (PDF) | CP.PMN.263 | October 1, 2025 |
| Etelcalcetide (Parsabiv) (PDF) | CP.PHAR.379 | October 1, 2025 |
| Eteplirsen (Exondys 51) (PDF) | CP.PHAR.288 | April 1, 2025 |
| Etranacogene Dezaparvovec (Hemgenix) (PDF) | CP.PHAR.580 | April 1, 2025 |
| Everolimus (Afinitor, Afinitor Disperz, Zortress)(PDF) | CP.PHAR.63 | April 1, 2025 |
| Evinacumab-dgnb (Evkeeza) (PDF) | CP.PHAR.511 | March 1, 2022 |
| Evinacumab-dgnb (Evkeeza) (PDF) | HIM.PA.166 | April 1, 2025 |
| Evolocumab (Repatha) (PDF) | HIM.PA.156 | June 1, 2025 |
| Exagamglogene autotemcel (Casgevy) (PDF) | CP.PHAR.603 | June 1, 2025
|
| Factor IX (Human, Recombinant) (PDF) | CP.PHAR.218 | April 1, 2025 |
| Factor IX Complex Human (Bebulin®, Profilnine®) (PDF) | CP.PHAR.219 | April 1, 2025 |
| Factor VIIa, Recombinant (NovoSeven® RT) (PDF) | CP.PHAR.220 | June 1, 2025 |
| Factor VIII (PDF) | CP.PHAR.215 | August 1, 2025 |
| Factor VIII/von Willebrand Factor Complex (Human - Alphanate®, Humate-P®, Wilate®) (PDF) | CP.PHAR.216 | June 1, 2025 |
| Factor XIII A-Subunit, Recombinant (Tretten®) | CP.PHAR.222 | April 1, 2025 |
| Factor XIII, Human (Corifact®) (PDF) | CP.PHAR.221 | April 1, 2025 |
| Fam-trastuzumab Deruxtecan-nxki (Enhertu) (PDF) | CP.PHAR.456 | April 1, 2025 |
| Famotidine-Ibuprofen (Duexis) (PDF) | CP.PMN.120 | October 1, 2025 |
| Faricimab (Vabysmo) (PDF) | CP.PHAR.581 | April 1, 2025 |
| Febuxostat (Uloric) (PDF) | CP.PMN.57 | April 1, 2025 |
| Fecal microbiota, live-jslm (Rebyota) (PDF) | CP.PHAR.613 | April 1, 2025 |
| Fecal microbiota spores, live-brpk (Vowst) (PDF) | CP.PHAR.632 | October 1, 2025 |
| Fedratinib (Inrebic) (PDF) | CP.PHAR.442 | January 1, 2025 |
| Fenfluramine (Fintepla) (PDF) | CP.PMN.246 | October 1, 2025 |
| Fentanyl IR (Abstral, Actiq, Fentora, Lazanda, Subsys) (PDF) | CP.PMN.127 | July 1, 2025 |
| Ferric Carboxymaltose (Injectafer) (PDF) | CP.PHAR.234 | April 1, 2025 |
| Ferric Derisomaltose (Monoferric) (PDF) | CP.PHAR.480 | July 1, 2025 |
| Ferric gluconate (Ferrlecit®) (PDF) | CP.PHAR.166 | July 1, 2023 |
| Ferric Maltol (Accrufer) (PDF) | CP.PMN.213 | January 1, 2025 |
| Ferric Pyrophosphate (Triferic, Triferic Avnu) (PDF) | CP.PHAR.624 | July 1, 2025 |
| Ferumoxytol (Feraheme®) (PDF) | CP.PHAR.165 | April 1, 2025 |
| Fezolinetant (Veozah) (PDF) | CP.PMN.289 | October 1, 2025 |
| Fidanacogene Elaparvovec-dzkt (Beqvez) (PDF) | CP.PHAR.643 | January 1, 2025 |
| Flibanserin (Addyi) (PDF) | CP.PHAR.446 | January 1, 2025 |
| Fibrinogen concentrate (human) (Fibryga, RiaSTAP) (PDF) | CP.PHAR.526 | July 1, 2025 |
| Filgrastim (Neupogen), Filgrastim-sndz (Zarxio), Tbo-filgrastim (Granix) (PDF) | CP.PHAR.297 | October 1, 2025 |
| Finerenone (Kerendia) (PDF) | CP.PMN.266 | January 1, 2025 |
| Fingolimod (Gilenya, Tascenso ODT) (PDF) | CP.PCH.38 | July 1, 2025 |
| Fingolimod (Gilenya, Tascenso ODT) (PDF) | CP.PHAR.251 | October 1, 2025 |
| Fitusiran (Qfitlia) (PDF) | CP.PHAR.706 | June 1, 2024 |
| Fluorouracil Cream (Tolak) (PDF) | CP.PMN.165 | January 1, 2025 |
| Fluticasone Propionate (Xhance) (PDF) | CP.PMN.95 | October 1, 2025 |
| Fondaparinux (Arixtra) (PDF) | CP.PHAR.226 | April 1, 2025 |
| No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update (PDF) | HIM.PA.33 | January 1, 2025 |
| Fosdenopterin (Nulibry) (PDF) | CP.PHAR.471 | July 1, 2025 |
| Fostamatinib (Tavalisse) (PDF) | CP.PHAR.24 | April 1, 2025 |
| Fostemsavir (Rukobia) (PDF) | CP.PHAR.516 | October 1, 2025 |
| Fremanezumb-vfrm (PDF) | HIM.PA.SP66 | March 1, 2025 |
| Fruquintinib (Fruzaqla) (PDF) | CP.PHAR.666 | April 1, 2025 |
| Fulvestrant (Faslodex Injection) (PDF) | CP.PHAR.424 | December 1, 2025 |
| Furosemide (Furoscix) (PDF) | CP.PHAR.608 | July 1, 2025 |
| Futibatinib (Lytgobi) (PDF) | CP.PHAR.604 | April 1, 2025 |
| Gabapentin ER (Gralise, Horizant) (PDF) | CP.PMN.240 | December 1, 2025 |
| Galcanezumab-gnlm (Emgality) (PDF) | HIM.PA.SP67 | October 1, 2025 |
| Galsulfase (Naglazyme) (PDF) | CP.PHAR.161 | July 1, 2025 |
| Ganaxolone (Ztalmy) (PDF) | CP.PMN.278 | July 1, 2025 |
| Garadacimab (CSL312)_PEPP (PDF) | CP.PHAR.673 | October 1, 2025 |
| Gefitinib (Iressa) (PDF) | CP.PHAR.68 | July 1, 2025 |
| Gemtuzumab ozogamicin (Mylotarg®) (PDF) | CP.PHAR.358 | January 1, 2025 |
| Gilteritinib (Xospata) (PDF) | CP.PHAR.412 | April 1, 2025 |
| Givinostat (ITF2357) (PDF) | CP.PHAR.644 | October 1, 2025 |
| Givosiran (Givlaari) (PDF) | CP.PHAR.457 | April 1, 2025 |
| Glasdegib (Daurismo)(PDF) | CP.PHAR.413 | April 1, 2025 |
| Glatiramer (Copaxone, Glatopa) (PDF) | CP.PHAR.252 | July 1, 2025 |
| Glaucoma Agents (Omlonti, Rhopressa, Rocklatan, Vyzulta) (PDF) | CP.PMN.286 | April 1, 2025 |
| Glecaprevir-Pibrentasvir (PDF) | HIM.PA.SP36 | December 1, 2025 |
| Glofitamab-gxbm (Columvi) (PDF) | CP.PHAR.636 | October 1, 2025 |
| Glucagon-Like Peptide-1 Receptor Agonists (PDF) | HIM.PA.53 | June 1, 2025 |
| Glycerol phenylbutyrate (Ravicti®) (PDF) | CP.PHAR.207 | April 1, 2025 |
| Golodirsen (Vyondys 53) (PDF) | CP.PHAR.453 | April 1, 2025 |
| Goserelin acetate (Zoladex®) (PDF) | CP.PHAR.171 | June 1, 2025 |
| Granisetron (Kytril, Sancuso, Sustol) (PDF) | CP.PMN.74 | October 1, 2025 |
| Halcinonide (Halog) (PDF) | HIM.PA.20 | January 1, 2025 |
| Halobetasol Propionate Lotion (Bryhali, Lexette, Ultravate) (PDF) | CP.PMN.180 | January 1, 2025 |
| Halobetasol Propionate/Tazarotene (Duobrii) (PDF) | CP.PMN.208 | October 1, 2025 |
| Hemin (Panhematin®) (PDF) | CP.PHAR.181 | April 1, 2025 |
| Histrelin acetate (Vantas®, Supprelin LA®) (PDF) | CP.PHAR.172 | July 1, 2025 |
| House dust mite allergen extract (Odactra®) (PDF) | CP.PMN.111 | October 1, 2025 |
| Human Growth Hormone (Somapacitan, Somatropin) (PDF) | HIM.PA.161 | April 1, 2025 |
| Hyaluronate Derivatives (PDF) | CP.PHAR.05 | January 1, 2025 |
| Hydroxyprogesterone Caproate (Makena/compound) (PDF) | CP.PHAR.14 | July 1, 2025 |
| Hydroxyurea (Siklos, Xromi) (PDF) | CP.PMN.193 | July 1, 2025 |
| ibalizumab-uiyk (Trogarzo) (PDF) | CP.PHAR.378 | October 1, 2025 |
| Ibandronate sodium (PDF) | CP.PHAR.189 | October 1, 2025 |
| Ibrutinib (Imbruvica) (PDF) | CP.PHAR.126 | June 1, 2024 |
| Icatibant (Firazyr®) (PDF) | CP.PHAR.178 | October 1, 2025 |
| Icosapent ethyl (Vascepa) (PDF) | CP.PMN.187 | April 1, 2025 |
| Idecabtagene vicleucel (Abecma) (PDF) | CP.PHAR.481 | July 1, 2025 |
| Idelalisib (Zydelig) (PDF) | CP.PHAR.133 | March 1, 2025 |
| Idursulfase (Elaprase) (PDF) | CP.PHAR.156 | July 1, 2025 |
| Iloperidone (Fanapt) (PDF) | CP.PMN.32 | October 1, 2025 |
| Iloprost (Ventavis®) (PDF) | CP.PHAR.193 | April 1, 2025 |
| Imatinib (Gleevec, Imkeldi) (PDF) | CP.PHAR.65 | July 1, 2025
|
| Imetelstat (Rytelo) (PDF) | CP.PHAR.690 | October 1, 2025
|
| Imiglucerase (Cerezyme) (PDF) | CP.PHAR.154 | July 1, 2025 |
| Immune Globulins (PDF) | CP.PHAR.103 | October 1, 2025 |
| Immune Globulins for PANS/PANDAS (PDF) | AR.CP.PHAR.103 | February 1, 2025 |
| Inavolisib (Itovebi) (PDF) | CP.PHAR.702 | January 1, 2025 |
| IncobotulinumtoxinA (Xeomin) (PDF) | CP.PHAR.231 | October 1, 2025 |
| Inhaled Agents for Asthma and COPD (PDF) | HIM.PA.153 | October 1, 2025 |
| Infertility and Fertility Preservation (PDF) | CP.PHAR.131 | March 1, 2025 |
| Inclisiran (Leqvio) (PDF) | CP.PHAR.568 | October 1, 2025 |
| Inebilizumab (PDF) | CP.PHAR.458 | December 1, 2025 |
| Inotersen (Tegsedi) (PDF) | CP.PHAR.405 | July 1, 2025 |
| inotuzumab ozogamicin (Besponsa®) (PDF) | CP.PHAR.359 | January 1, 2025 |
| Insulin Delivery Systems (V-Go, Omnipod, InPen) (PDF) | CP.PHAR.534 | October 1, 2025 |
| Insulin detemir (Levemir) (PDF) | HIM.PA.171 | June 1, 2025 |
| Insulin glargine (Rezvoglar, Semglee, Toujeo) (PDF) | HIM.PA.09 | October 1, 2025 |
| Interferon Beta-1a (Avonex, Rebif) (PDF) | CP.PHAR.255 | July 1, 2025 |
| Interferon beta-1b (Betaseron, Extavia) (PDF) | CP.PCH.46 | October 1, 2025 |
| Interferon Gamma- 1b (Actimmune) (PDF) | CP.PHAR.52 | April 1, 2025 |
| Intrathecal Baclofen (Gablofen, Lioresal) (PDF) | CP.PHAR.149 | December 1, 2023 |
| Iobenguane I-131 (Azedra) (PDF) | CP.PHAR.459 | April 1, 2025 |
| Ipilimumab (Yervoy) (PDF) | CP.PHAR.319 | October 1, 2025 |
| Ipilimumab (Yervoy) (PDF) | CP.PHAR.319 | Version effective until October 1, 2025 |
| Iptacopan (LNP023) (PDF) | CP.PHAR.656 | December 1, 2025 |
| Irinotecan Liposome (Onivyde) (PDF) | CP.PHAR.304 | January 1, 2025 |
| Iron sucrose (Venofer®) (PDF) | CP.PHAR.167 | July 1, 2023 |
| Isatuximab-irfc (Sarclisa) (PDF) | CP.PHAR.482 | July 1, 2025
|
| isavuconazonium (Cresemba®) (PDF) | CP.PMN.154 | July 1, 2025 |
| Isotretinoin (Claravis, Absorica, Absorica LD, Myorisan, Zenatane, Amnesteem) (PDF) | CP.PMN.143 | March 1, 2025 |
| Istradefylline (Nourianz) (PDF) | CP.PMN.217 | April 1, 2025 |
| Itraconazole (Sporanox, Tolsura) (PDF) | CP.PMN.124 | July 1, 2025 |
| Ivabradine (Corlanor) (PDF) | CP.PMN.70 | June 1, 2025 |
| Ivacaftor (Kalydeco) (PDF) | CP.PHAR.210 | December 1, 2025 |
| Ivermectin (Stromectol, Sklice) | CP.PMN.269 | October 1, 2025 |
| Ivosidenib (Tibsovo) (PDF) | CP.PHAR.137 | January 1, 2025 |
| Ixazomib (Ninlaro) (PDF) | CP.PHAR.302 | December 1, 2025 |
| Ketamine (Ketalar) (PDF) | CP.PMN.296 | October 1, 2025 |
| Ketorolac nasal spray (Sprix) (PDF) | CP.PMN.282 | March 1, 2025 |
| Lacosamide (Vimpat) (PDF) | CP.PMN.155 | August 1, 2022 |
| L-glutamine (Endari) (PDF) | CP.PMN.116 | March 1, 2025 |
| Lactic Acid/Citric Acid/Potassium Bitartrate (Phexxi) (PDF) | CP.PMN.251 | December 1, 2022 |
| Lanadelumab-fylo (Takhzyro) (PDF) | HIM.PA.172 | October 1, 2025 |
| Lanreotide (Somatuline Depot and Unbranded) (PDF) | CP.PHAR.391 | January 1, 2025 |
| lapatinib (Tykerb®) (PDF) | CP.PHAR.79 | March 1, 2025 |
| Laronidase (Aldurazyme) (PDF) | CP.PHAR.152 | July 1, 2025 |
| Larotrectinib (Vitrakvi)(PDF) | CP.PHAR.414 | October 1, 2025 |
| Lasmiditan (Reyvow) (PDF) | CP.PMN.218 | June 1, 2025 |
| Latanoprostene Bunod (Vyzulta) (PDF) | CP.PMN.108 | May 1, 2023 |
| Lazertinib (Lazcluze) (PDF) | CP.PHAR.695 | January 1, 2025 |
| Lebrikizumab (Ebglyss) (PDF) | CP.PHAR.704 | January 1, 2025 |
| Lecanemab-irmb (Leqembi) (PDF) | CP.PHAR.596 | September 1, 2025 |
| Ledipasvir-Sofosbuvir (Harvoni) (PDF) | HIM.PA.SP3 | December 1, 2025 |
| Lefamulin (Xenleta) (PDF) | CP.PMN.219 | October 1, 2025 |
| Lenacapavir (Sunlenca) (PDF) | CP.PHAR.622 | October 1, 2025 |
| Lenalidomide (Revlimid) (PDF) | CP.PHAR.71 | September 1, 2025 |
| Lenvatinib (Lenvima) (PDF) | CP.PHAR.138 | May 1, 2025 |
| Leniolisib (Joenja) (PDF) | CP.PHAR.597 | January 1, 2025 |
| Letermovir (Prevymis) (PDF) | CP.PHAR.367 | October 1, 2025 |
| Letermovir (Prevymis) (PDF) | CP.PHAR.367 | Version effective until October 1, 2025 |
| Leucovorin Injection (PDF) | CP.PHAR.393 | December 1, 2023 |
| Levacetylleucine (Aqneursa) (PDF) | CP.PHAR.682 | October 1, 2025 |
| Levodopa Inhalation Powder (Inbrija) (PDF) | CP.PMN.267 | January 1, 2025 |
| Levoleucovorin (Fusilev, Khapzory) (PDF) | CP.PHAR.151 | January 1, 2025 |
| Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) (PDF) | CP.PHAR.173 | January 1, 2025 |
| Leuprolide Acetate (Lupron, Eligard, Lupaneta Pack, Fensolvi, Camcevi) (PDF) | CP.PCH.53 | June 1, 2025 |
| Levoketoconazole (Recorlev) (PDF) | CP.PMN.275 | July 1, 2025 |
| Levomilnacipran (Fetzima) (PDF) | HIM.PA.125 | October 1, 2025 |
| Lidocaine Transdermal (Lidoderm, ZTlido) (PDF) | CP.PMN.08 | October 1, 2025 |
| Lifileucel (Amtagvi) (PDF) | CP.PHAR.598 | January 1, 2025 |
| Lifitegrast (Xiidra®) (PDF) | CP.PMN.73 | April 1, 2025 |
| Linaclotide (Linzess) (PDF) | CP.PMN.71 | December 1, 2023 |
| Linezolid (Zyvox) (PDF) | CP.PMN.27 | October 1, 2025 |
| Linvoseltamab-gcpt (Lynozyfic) (PDF) | CP.PHAR.743 | October 1, 2025 |
| Lisocabtagene Maraleucel (Breyanzi) (PDF) | CP.PHAR.483 | July 1, 2025 |
| Lofexidine (Lucemyra) (PDF) | CP.PMN.152 | October 1, 2025 |
| Lomustine (Gleostine) (PDF) | CP.PHAR.507 | January 1, 2025 |
| Lonafarnib (Zokinvy) (PDF) | CP.PHAR.499 | April 1, 2025 |
| Loncastuximab tesirine-lpyl (Zynlonta) (PDF) | CP.PHAR.539 | October 1, 2025 |
| Lorlatinib (Lorbrena)(PDF) | CP.PHAR.406 | September 1, 2025 |
| Loteprednol etabonate (Eysuvis) (PDF) | CP.PMN.260 | April 1, 2025 |
| Lotilaner (Xdemvy) (PDF) | CP.PMN.291 | January 1, 2025 |
| Lovotibeglogene Autotemcel (Lovo-Cel) (PDF) | CP.PHAR.627 | June 1, 2025 |
| Lubiprostone (Amitiza) (PDF) | CP.PMN.142 | January 1, 2025 |
| Luliconazole Cream (Luzu) (PDF) | CP.PMN.166 | April 1, 2025 |
| Lumacaftor-Ivacaftor (Orkambi) (PDF) | CP.PHAR.213 | December 1, 2025 |
| Lumasiran (Oxlumo) (PDF) | CP.PHAR.473 | April 1, 2025 |
| Lumateperone (Caplyta) (PDF) | CP.PMN.232 | October 1, 2025 |
| Lurbinectedin (Zepzelca) (PDF) | CP.PHAR.500 | October 1, 2025 |
| Lurasidone (Latuda) (PDF) | CP.PMN.50 | March 1, 2023 |
| Luspatercept-aamt (Reblozyl) (PDF) | CP.PHAR.450 | April 1, 2025 |
| Lusutrombopag (Mulpleta)(PDF) | CP.PHAR.407 | April 1, 2025 |
| Lutetium Lu 177 Dotatate (Lutathera) (PDF) | CP.PHAR.384 | October 1, 2025 |
| Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) 09.09.22.docx | CP.PHAR.582 | July 1, 2025 |
| Macitentan (Opsumit) (PDF) | CP.PHAR.194 | April 1, 2025 |
| Macitentan (Opsumit®) (PDF) | CP.PCH.31 | March 1, 2022 |
| Mannitol (Bronchitol) (PDF) | CP.PHAR.518 | October 1, 2025 |
| Maralixibat (Livmarli) (PDF) | CP.PHAR.543 | December 1, 2025 |
| Margetuximab-cmkb (Margenza) (PDF) | CP.PHAR.522 | April 1, 2025 |
| Maribavir (Livtencity) (PDF) | CP.PMN.271 | April 1, 2025 |
| Marstacimab-hncq (Hympavzi) (PDF) | CP.PHAR.674 | August 1, 2025 |
| Mavacamten (MYK-461) (PDF) | CP.PMN.272 | October 1, 2025 |
| Mavorixafor (Xolremdi) | CP.PHAR.679 | July 1, 2025 |
| Mecamylamine (Vecamyl) (PDF) | CP.PMN.136 | July 1, 2025 |
| Mecasermin (Increlex) (PDF) | CP.PHAR.150 | October 1, 2025 |
| Mechlorethamine (Valchlor) (PDF) | CP.PHAR.381 | October 1, 2025 |
| Megestrol Acetate 125 mg/mL Oral Suspension (Megace ES) (PDF) | CP.PMN.179 | January 1, 2025 |
| Melphalan (Hepzato) (PDF) | CP.PHAR.653 | January 1, 2025 |
| Melphalan flufenamide (Pepaxto) (PDF) | CP.PHAR.535 | July 1, 2025 |
| Memantine (Namenda XR, Namzaric) (PDF) | CP.PCH.30 | October 1, 2025 |
| Mepolizumab (Nucala) (PDF) | HIM.PA.175 | October 1, 2025 |
| Mercaptopurine (Purixan) (PDF) | CP.PHAR.447 | version effective until December 1, 2025 |
| Mercaptopurine (Purixan) (PDF) | CP.PHAR.447 | December 1, 2025 |
| Metformin ER (Glumetza, Fortamet) (PDF) | CP.PMN.72 | April 1, 2025 |
| Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex) (PDF) | CP.PHAR.134 | January 1, 2025 |
| Methoxsalen (Uvadex) (PDF) | HIM.PA.17 | January 1, 2025 |
| Methoxy polyethylene glycol-epoetin beta (Mircera) (PDF) | CP.PHAR.238 | September 1, 2025 |
| Methylnaltrexone Bromide (Relistor) (PDF) | CP.PMN.169 | December 1, 2025 |
| Metoclopramide (Gimoti) (PDF) | CP.PMN.252 | March 1, 2025 |
| Metreleptin (Myalept) (PDF) | CP.PHAR.425 | October 1, 2025 |
| Midazolam (Nayzilam) (PDF) | CP.PMN.211 | October 1, 2025 |
| Midostaurin (Rydapt) (PDF) | CP.PHAR.344 | July 1, 2025 |
| Mifepristone (Korlym) (PDF) | CP.PHAR.101 | June 1, 2025 |
| Migalastat (Galafold) (PDF) | CP.PHAR.394 | July 1, 2025 |
| Miglustat (Zavesca) (PDF) | CP.PHAR.164 | September 1, 2025 |
| Milnacipran (Savella) (PDF) | CP.PMN.125 | October 1, 2025 |
| Minocycline ER (Solodyn, Ximino, Minolira), Microspheres (Arestin), Foam (Zilxi) (PDF) | CP.PMN.80 | October 1, 2025 |
| Minocycline micronized foam (Amzeeq) (PDF) | CP.PMN.242 | December 1, 2022 |
| Mirdametinib (Gomekli) (PDF) | CP.PHAR.718 | July 1, 2025 |
| Mirvetuximab soravtansine-gynx (Elahere) (PDF) | CP.PHAR.617 | April 1, 2025 |
| Mitapivat (Pyrukynd) (PDF) | CP.PHAR.558 | January 1, 2025 |
| Mitomycin for Pyelocalyceal Solution (Jelmyto) (PDF) | CP.PHAR.495 | December 1, 2025 |
| Mitoxantrone (PDF) | CP.PHAR.258 | July 1, 2025 |
| Mixed pollens allergen extract (Oralair) (PDF) | CP.PMN.85 | October 1, 2025 |
| Mobocertinib (Exkivity) (PDF) | CP.PHAR.559 | January 1, 2025 |
| Modafinil (Provigil) (PDF) | CP.PMN.39 | July 1, 2025 |
| Mogamulizumab-kpkc (Poteligeo) (PDF) | CP.PHAR.139 | March 1, 2025 |
| Momelotinib (Ojjaara) (PDF) | CP.PHAR.654 | January 1, 2025 |
| Mometasone furoate (Sinuva) (PDF) | CP.PHAR.448 | October 1, 2025 |
| Mometasone (Nasonex) (PDF) | HIM.PA.93 | October 1, 2025 |
| Montelukast oral granules (Singulair) (PDF) | HIM.PA.129 | December 1, 2023 |
| Mosunetuzumab-axgb (Lunsumio) (PDF) | CP.PHAR.618 | April 1, 2025 |
| Motixafortide (Aphexda) (PDF) | CP.PHAR.655 | January 1, 2025 |
| Moxetumomab pasudotox-tdfk (Lumoxiti) (PDF) | CP.PHAR.398 | January 1, 2025 |
| Nabumatone Double-Strength (Relafen DS) (PDF) | CP.PMN.287 | October 1, 2025 |
| Nadofaragene Firadenovec (Instiladrin)(PDF) | CP.PHAR.461 | March 1, 2025 |
| Nafarelin acetate (Synarel®) (PDF) | CP.PHAR.174 | July 1, 2025 |
| Naldemedine (Symproic) (PDF) | CP.PMN.112 | January 1, 2025 |
| Nalmefene (Opvee) (PDF) | CP.PHAR.638 | October 1, 2025 |
| Naloxegol (Movantik) (PDF) | HIM.PA.167 | January 1, 2025 |
| Naproxen/Esomeprazole (Vimovo) (PDF) | CP.PMN.117 | October 1, 2025 |
| Naproxen oral suspension (Naprosyn) (PDF) | HIM.PA.130 | January 1, 2025 |
| Narsoplimab (OMS721) (PDF) | CP.PHAR.527 | June 1, 2024 |
| Natalizumab (Tysabri) (PDF) | CP.PHAR.259 | October 1, 2025 |
| Naxitamab-gqgk (Danyelza) | CP.PHAR.523 | April 1, 2025 |
| Necitumumab (Portrazza®) (PDF) | CP.PHAR.320 | January 1, 2025 |
| Nedosiran (DCR-PHXC) (PDF) | CP.PHAR.619 | September 1, 2025 |
| Nemolizumab-ito (Nemluvio) (PDF) | CP.PHAR.703 | June 1, 2025 |
| Neomycin/Fluocinolone Cream (Neo-Synalar) (PDF) | CP.PMN.167 | January 1, 2025 |
| Neratinib (Nerlynx) (PDF) | CP.PHAR.365 | January 1, 2025 |
| Netarsudil (Rhopressa), Netarsudil-Latanoprost (Rocklatan) (PDF) | CP.PMN.118 | May 1, 2023 |
| Netupitant and Palonosetron (Akynzeo) (PDF) | CP.PMN.158 | October 1, 2025 |
| Nifurtimox (Lampit) ^ (PDF) | CP.PMN.256 | March 1, 2025 |
| Nilotinib (Tasigna, Danziten) (PDF) | CP.PHAR.76 | July 1, 2025 |
| Nintedanib (Ofev) (PDF) | CP.PCH.54 | October 1, 2025 |
| Nipocalimab-aahu (Imaavy) (PDF) | CP.PHAR.720 | August 1, 2025 |
| Nitisinone (Nityr, Orfadin) (PDF) | CP.PHAR.132 | October 1, 2025 |
| Niraparib (Zejula) (PDF) | CP.PHAR.408 | December 1, 2025 |
| Niraparib and Abiraterone (Akeega) (PDF) | CP.PHAR.645 | March 1, 2025 |
| Nirmatrelvir-Ritonavir (Paxlovid) (PDF) | CP.PMN.288 | October 1, 2025 |
| Nirogacestat (Ogsiveo) (PDF) | CP.PHAR.671 | April 1, 2025 |
| Nirsevimab (Beyfortus) (PDF) | CP.PHAR.614 | October 1, 2025 |
| Nitazoxanide (Alinia) (PDF) | HIM.PA.152 | March 1, 2025 |
| Nivolumab, Nivolumab Hyaluronidase-nvhy (Opdivo, Opdivo Qvantig) (PDF) | CP.PHAR.121 | December 1, 2025 |
| Nivolumab, Nivolumab Hyaluronidase-nvhy (Opdivo, Opdivo Qvantig) (PDF) | CP.PHAR.121 | Version effective until December 1, 2025 |
| Nivolumab and Relatlimab (Opdualag) (PDF) | CP.PHAR.588 | October 1, 2025 |
| Nogapendekin alfa inbakicept-pmln (Anktiva) (PDF) | CP.PHAR.684 | October 1, 2025 |
| Non-Calcium Phosphate Binders (Auryxia, Fosrenol, Renagel, Renvela, Velphoro) (PDF) | CP.PMN.04 | September 1, 2025
|
| Non-Formulary and Formulary Contraceptives (PDF) | HIM.PA.100 | July 1, 2025 |
| Non-Formulary Test Strips (PDF) | HIM.PA.34 | April 1, 2025 |
| Nusinersen (Spinraza®) (PDF) | CP.PHAR.327 | October 1, 2025 |
| Obecabtagene autoleucel (Aucatzyl) (PDF) | CP.PHAR.675 | August 1, 2025 |
| Obeticholic acid (Ocaliva) (PDF) | CP.PHAR.287 | October 1, 2025 |
| Obinutuzumab (Gazyva®) (PDF) | CP.PHAR.305 | January 1, 2025 |
| Ocrelizumab (Ocrevus) (PDF) | CP.PHAR.335 | October 1, 2025
|
| Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Bynfezia, Mycapssa) (PDF) | CP.PHAR.40 | June 1, 2025 |
| Odevixibat (Bylvay) (PDF) | CP.PHAR.528 | September 1, 2025 |
| Ofatumumab (Arzerra, Kesimpta) (PDF) | CP.PHAR.306 | October 1, 2025 |
| Off-label Policy (PDF) | HIM.PA.154 | January 1, 2025 |
| Olanzapine Long-Acting Injection (Zyprexa Relprevv) (PDF) | CP.PHAR.292 | October 1, 2025 |
| Olanzapine-samidorphan (Lybalvi) (PDF) | CP.PMN.265 | October 1, 2025 |
| Olaparib (Lynparza) (PDF) | CP.PHAR.360 | April 1, 2025 |
| Olaratumab (Lartruvo®) (PDF) | CP.PHAR.326 | December 1, 2023 |
| Olezarsen (Tryngolza) (PDF) | CP.PHAR.689 | October 1, 2025 |
| Olipudase alfa-rpcp (Xenpozyme) 09.08.22.docx | CP.PHAR.586 | October 1, 2025 |
| Olutasidenib (Rezlidhia) (PDF) | CP.PHAR.615 | April 1, 2025 |
| Omacetaxine (Synribo) (PDF) | CP.PHAR.108 | September 1, 2025 |
| Omadacycline (Nuzyra)(PDF) | CP.PMN.188 | October 1, 2025 |
| Omalizumab (Xolair) (PDF) | CP.PCH.49 | June 1, 2025 |
| Omalizumab (Xolair®) (PDF) | CP.PHAR.01 | August 1, 2024 |
| Omaveloxolone (Skyclarys) (PDF) | CP.PHAR.590 | July 1, 2025 |
| Omburtamab (Omblastys) (PDF) | CP.PHAR.585 | December 1, 2023 |
| OnabotulinumtoxinA (Botox) (PDF) | CP.PHAR.232 | October 1, 2025 |
| Onasemnogene abeparvovec (Zolgensma) (PDF) | CP.PHAR.421 | July 1, 2025 |
| Ondansetron (Zuplenz) (PDF) | CP.PMN.45 | August 1, 2024 |
| Ophthalmic Corticosteroids (PDF) | HIM.PA.03 | January 1, 2025 |
| Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (PDF) | CP.PHAR.536 | July 1, 2025 |
| Opicapone (Ongentys) (PDF) | CP.PMN.245 | October 1, 2025 |
| Opioid Analgesics (PDF) | HIM.PA.139 | October 1, 2025 |
| Osilodrostat (Isturisa) (PDF) | CP.PHAR.487 | October 1, 2025 |
| Osimertinib (Tagrisso) (PDF) | CP.PHAR.294 | July 1, 2025
|
| Ospemifene (Osphena) (PDF) | CP.PMN.168 | January 1, 2025 |
| Overactive Bladder Agents (PDF) | CP.PMN.198 | September 1, 2025 |
| Oxymetazoline (Rhofade, Upneeq) (PDF) | CP.PMN.86 | October 1, 2025 |
| Ozanimod (Zeposia) (PDF) | CP.PHAR.462 | October 1, 2025 |
| Ozenoxacin (Xepi) (PDF) | CP.PMN.119 | October 1, 2025 |
| Paclitaxel, Protein-Bound (Abraxane) (PDF) | CP.PHAR.176 | October 1, 2025
|
| Pacritinib (Vonjo) (PDF) | CP.PHAR.583 | July 1, 2025 |
| Palbociclib (Ibrance) (PDF) | HIM.PA.173 | July 1, 2025 |
| Paliperidone inj (Invega Sustenna, Invega Trinza, Invega Hafyera) (PDF) | CP.PHAR.291 | October 1, 2025 |
| Palivizumab (Synagis) (PDF) | CP.PHAR.16 | October 1, 2025 |
| Palopegteriparatide (Yorvipath) (PDF) | CP.PHAR.696 | January 1, 2025 |
| Palovarotene (PDF) | CP.PHAR.548 | October 1, 2025 |
| Pancrelipase (Creon, Pancreaze, Pertyze, Viokace, Zenpep) (PDF) | CP.PCH.44 | March 1, 2025 |
| Panitumumab (Vectibix®) (PDF) | CP.PHAR.321 | May 1, 2025 |
| Panobinostat (Farydak) (PDF) | CP.PHAR.382 | September 1, 2024 |
| Parathyroid Hormone (Natpara) (PDF) | CP.PHAR.282 | April 1, 2025 |
| Paricalcitol Injection (Zemplar) (PDF) | CP.PHAR.270 | October 1, 2025 |
| Pasireotide (Signifor LAR®) (PDF) | CP.PHAR.332 | January 1, 2025 |
| Patiromer (Veltassa) (PDF) | CP.PMN.205 | October 1, 2025 |
| Patisiran (Onpattro) (PDF) | CP.PHAR.395 | July 1, 2025 |
| Pazopanib (Votrient) (PDF) | CP.PHAR.81 | December 1, 2025 |
| Peanut allergen powder (Palforzia) (PDF) | CP.PMN.220 | October 1, 2025 |
| Pegaptanib (Macugen) (PDF) | CP.PHAR.185 | May 1, 2023 |
| Pegaspargase (Oncaspar), Calaspargase pegol-mknl (Asparlas) (PDF) | CP.PHAR.353 | March 1, 2025 |
| Pegcetacoplan (Empaveli0 (PDF) | CP.PHAR.524 | December 1, 2025 |
| Pegfilgrastim/Biosimilars, Eflapegrastim, Efbemalenograstim (PDF) | CP.PHAR.296 | October 1, 2025 |
| Peginterferon Alfa-2a (Pegasys) (PDF) | CP.PHAR.89 | December 1, 2025 |
| Peginterferon beta-1a (Plegridy) (PDF) | CP.PHAR.271 | July 1, 2025 |
| Pegloticase (Krystexxa) (PDF) | CP.PHAR.115 | April 1, 2025 |
| Pegunigalsidase Alfa (PRX-102) (PDF) | CP.PHAR.512 | September 1, 2025 |
| Pegvaliase-pqpz (Palynziq) (PDF) | CP.PHAR.140 | March 1, 2025 |
| Pegvisomant (Somavert) (PDF) | CP.PHAR.389 | January 1, 2025 |
| Pembrolizumab (Keytruda®) (PDF) | CP.PHAR.322 | October 1, 2025 |
| Pemetrexed (Alimta, Pemfexy) (PDF) | CP.PHAR.368 | June 1, 2025
|
| Pemigatinib (Pemazyre) (PDF) | CP.PHAR.496 | December 1, 2025 |
| Penicillamine (Cuprimine) (PDF) | CP.PCH.09 | January 1, 2025 |
| Penpulimab-kcqx (PDF) | CP.PHAR.732 | October 1, 2025 |
| Pentosan polysulfate sodium (Elmiron) (PDF) | CP.PMN.276 | June 1, 2023 |
| Perampanel (Fycompa) (PDF) | CP.PMN.156 | October 1, 2025 |
| Perfluorohexyloctane (Miebo) (PDF) | CP.PMN.290 | October 1, 2025 |
| Pertuzumab (Perjeta) (PDF) | CP.PHAR.227 | September 1, 2025 |
| Pertuzumab-trastuzumab-hyaluronidase-zzxf (Phesgo) (PDF) | CP.PHAR.501 | October 1, 2025 |
| Pexidartinib (Turalio)(PDF) | CP.PHAR.436 | March 1, 2025 |
| Phendimetrazine (PDF) | CP.PCH.47 | July 1, 2025 |
| Phentermine (Adipex-P, Lomaira) (PDF) | CP.PCH.13 | July 1, 2025 |
| Pilocarpine (Vuity) (PDF) | CP.PMN.270 | January 1, 2025 |
| Pimavanserin (Nuplazid) (PDF) | CP.PMN.140 | October 1, 2025 |
| Pirfenidone (Esbriet) (PDF) | CP.PHAR.286 | October 1, 2025 |
| Pirtobrutinib (Jaypirca) (PDF) | CP.PHAR.620 | July 1, 2025 |
| Pitolisant (Wakix) (PDF) | CP.PMN.221 | October 1, 2025 |
| Plasminogen, Human-tvmh (Ryplazim) (PDF) | CP.PHAR.513 | January 1, 2025 |
| Plecanatide (Trulance) (PDF) | CP.PMN.87 | January 1, 2025 |
| Plerixafor (Mozobil) (PDF) | CP.PHAR.323 | October 1, 2025 |
| Polatuzumab Vedotin-piiq (Polivy) (PDF) | CP.PHAR.433 | October 1, 2025 |
| Pomalidomide (Pomalyst) (PDF) | CP.PHAR.116 | July 1, 2025 |
| Ponatinib (Iclusig) (PDF) | CP.PHAR.112 | July 1, 2025 |
| Ponesimod (Ponvory) (PDF) | CP.PHAR.537 | October 1, 2025 |
| Potassium (Klor-Con) (PDF) | HIM.PA.143 | April 1, 2025 |
| Pozelimab-bbfg (Veopoz) (PDF) | CP.PHAR.626 | September 1, 2025 |
| Prademagene Zamikeracel (EB-101) (PDF) | CP.PHAR.609 | October 1, 2025 |
| Pralatrexate (Folotyn®) (PDF) | CP.PHAR.313 | March 1, 2025 |
| Pralsetinib (Gavreto) (PDF) | CP.PHAR.514 | June 1, 2023 |
| Pramlintide (Symlin) (PDF) | CP.PMN.129 | April 1, 2025 |
| Prasterone (Intrarosa) (PDF) | CP.PMN.99 | April 1, 2025 |
| Pregabalin (Lyrica, Lyrica CR) (PDF) | CP.PMN.33 | July 1, 2025 |
| Pretomanid (PDF) | CP.PMN.222 | April 1, 2025 |
| Progesterone (Crinone, Endometrin, Milprosa) (PDF) | CP.PMN.243 | October 1, 2025 |
| Propranolol HCl Oral Solution (Hemangeol) (PDF) | CP.PCH.51 | July 1, 2025 |
| protein c concentrate, human (Ceprotin®) (PDF) | CP.PHAR.330 | April 1, 2025 |
| propranolol HCL solution (Hemangeol) (PDF) | CP.PMN.58 | January 1, 2024 |
| Prucalopride (Motegrity) (PDF) | HIM.PA.159 | September 1, 2025 |
| Pyrimethamine (Daraprim®) (PDF) | CP.PMN.44 | October 1, 2025 |
| Quantity Limit Override and Dose Optimization (PDF) | CP.PMN.59 | January 1, 2025 |
| Quetiapine ER (Seroquel XR) (PDF) | CP.PMN.64 | April 1, 2025 |
| Quinine Sulfate (Qualaquin) (PDF) | CP.PMN.262 | October 1, 2025 |
| Quizartinib (Vanflyta) (PDF) | CP.PHAR.646 | January 1, 2025 |
| Ramucirumab (Cyramza) (PDF) | CP.PHAR.119 | July 1, 2025 |
| Ranibizumab (Lucentis, Susvimo), Lucentis Biosimilars (PDF) | CP.PHAR.186 | August 1, 2025 |
| Rasagiline (Azilect®) (PDF) | HIM.PA.89 | October 1, 2025 |
| Ravulizumab-cwvz (Ultomiris) (PDF) | CP.PHAR.415 | December 1, 2025 |
| Regorafenib (Stivarga) (PDF) | CP.PHAR.107 | July 1, 2025 |
| Relugolix (Orgovyx), Relugolix/Estradiol/Norethinedrone (Myfembree) (PDF) | CP.PHAR.529 | October 1, 2025 |
| Remestemcel-L (Ryoncil) (PDF) | CP.PHAR.474 | July 1, 2025 |
| Remetirom (Rezdiffra) (PDF) | CP.PHAR.647 | January 1, 2025 |
| Repository Corticotropin Injection (H.P. Acthar Gel) (PDF) | CP.PHAR.168 | May 1, 2023 |
| Repotrectinib (Augtyro) (PDF) | CP.PHAR.667 | April 1, 2025 |
| Respiratory Syncytial Virus Vaccine (Abrysvo) (PDF) | CP.PHAR.658 | January 1, 2025 |
| Reslizumab (Cinqair) (PDF) | CP.PHAR.223 | April 1, 2025 |
| Retifanlimab-dlwr (Zynyz) (PDF) | CP.PHAR.629 | August 1, 2025 |
| Revakinagene Taroretcel-lwey (Encelto) (PDF) | CP.PHAR.697 | July 1, 2024 |
| Revumenib (Revuforj) (PDF) | CP.PHAR.707 | April 1, 2025 |
| Ribavirin (Copegus, Moderiba, Rebetol, Ribasphere) (PDF) | CP.PHAR.141 | January 1, 2025 |
| Ribociclib (Kisqali, Kisqali Femara) (PDF) | CP.PHAR.334 | March 1, 2025 |
| Rifabutin (Mycobutin) (PDF) | CP.PMN.223 | April 1, 2025 |
| Rifamycin (Aemcolo) (PDF) | CP.PMN.196 | October 1, 2025 |
| Rifaximin (Xifaxan®) (PDF) | CP.PMN.47 | January 1, 2025 |
| Rilonacept (Arcalyst) (PDF) | CP.PHAR.266 | September 1, 2025 |
| Ripretinib (Qinlock) (PDF) | CP.PHAR.502 | October 1, 2025 |
| RimabotulinumtoxinB (Myobloc) (PDF) | CP.PHAR.233 | October 1, 2025 |
| Rimegepant (Nurtec ODT) (PDF) | CP.PHAR.490 | March 1, 2025 |
| Riociguat (Adempas®) (PDF) | CP.PHAR.195 | April 1, 2025 |
| Risdiplam (Evrysdi) (PDF) | CP.PHAR.477 | July 1, 2025 |
| Risedronate (Actonel, Atelvia) (PDF) | CP.PMN.100 | June 1, 2025 |
| Risperidone Long-Acting Injection (Risperdal Consta) (PDF) | CP.PHAR.293 | October 1, 2025 |
| Rituximab (Rituxan, Riabni, Ruxience, Truxima, Rituxan Hycela) (PDF) | CP.PHAR.260 | October 1, 2025 |
| Roflumilast (Daliresp, Zoryve) (PDF) | CP.PMN.46 | October 1, 2025 |
| Rolapitant (Varubi) (PDF) | CP.PMN.102 | October 1, 2025 |
| Romidepsin (Istodax®) (PDF) | CP.PHAR.314 | January 1, 2025 |
| Romiplostim (Nplate®) (PDF) | CP.PHAR.179 | April 1, 2025 |
| Romosozumab-aqqg (Evenity) (PDF) | CP.PHAR.428 | December 1, 2025 |
| Ropeginterferon alfa-2b-njft (Besremi) (PDF) | CP.PHAR.570 | April 1, 2025 |
| Rozanolixizumab-noli (Rystiggo) (PDF) | CP.PHAR.648 | March 1, 2025 |
| RP-L201 (PDF) | CP.PHAR.599 | December 1, 2023 |
| Rucaparib (Rubraca®) (PDF) | CP.PHAR.350 | April 1, 2025 |
| Rufinamide (Banzel) (PDF) | CP.PMN.157 | December 1, 2025 |
| Ruxolitinib (Jakafi) (PDF) | CP.PHAR.98 | April 1, 2025 |
| Sacituzumab Govitecan-hziy (Trodelvy) (PDF) | CP.PHAR.475 | July 1, 2025 |
| Sacubitril/Valsartan (Entresto) (PDF) | CP.PCH.52 | April 1, 2025 |
| Safinamide (Xadago) (PDF) | CP.PMN.113 | April 1, 2025 |
| Sapropterin Dihydrochloride (Kuvan, Javygtor) (PDF) | CP.PHAR.43 | September 1, 2025 |
| Sarecycline (Seysara) (PDF) | CP.PMN.189 | April 1, 2025 |
| Sargramostim (Leukine) (PDF) | CP.PHAR.295 | December 1, 2025 |
| Satralizumab-mwge (Enspryng) (PDF) | CP.PHAR.463 | December 1, 2025 |
| Sebelipase Alfa (Kanuma) (PDF) | CP.PHAR.159 | July 1, 2025 |
| Sebetralstat (Ekterly) (PDF) | CP.PHAR.723 | October 1, 2025 |
| Secnidazole (Solosec) (PDF) | CP.PMN.103 | April 1, 2025 |
| Seladelpar (Livdelzi) (PDF) | CP.PHAR.698 | January 1, 2025 |
| Selexipag (Uptravi®) (PDF) | CP.PHAR.196 | April 1, 2025 |
| Selinexor (Xpovio) (PDF) | CP.PHAR.431 | October 1, 2025 |
| Selpercatinib (Retevmo) (PDF) | CP.PHAR.478 | July 1, 2025 |
| Selumetinib (Koselugo) (PDF) | CP.PHAR.464 | June 1, 2025 |
| Semaglutide (Wegovy) (PDF) | CP.PMN.295 | October 1, 2025 |
| Setmelanotide (Imcivree) (PDF) | CP.PHAR.491 | July 1, 2025 |
| Short ragweed pollen allergen extract (Ragwitek) (PDF) | CP.PMN.83 | October 1, 2025 |
| Sildenafil (Revatio®) (PDF) | CP.PHAR.197 | April 1, 2025 |
| Sildenafil (Viagra) (PDF) | CP.PCH.07 | July 1, 2025 |
| Siponimod (Mayzent) (PDF) | CP.PHAR.427 | October 1, 2025 |
| Sipuleucel-T (Provenge) (PDF) | CP.PHAR.120 | June 1, 2024 |
| Sirolimus Protein-Bound Particles (Fyarro), topical gel (Hyftor) (PDF) | CP.PHAR.574 | April 1, 2025 |
| Siltuximab (Sylvant) (PDF) | CP.PHAR.329 | April 1, 2025 |
| Sodium Oxybate (Xyrem, Lumryz) and Calcium Magnesium Potassium Sodium Oxybate (Xywav) (PDF) | CP.PMN.42 | October 1, 2025 |
| Sodium-Glucose Co-Transporter 2 Inhibitors (PDF) | HIM.PA.91 | April 1, 2025 |
| Sodium Phenylbutyrate (Buphenyl) (PDF) | CP.PHAR.208 | April 1, 2025 |
| Sodium Phenylbutyrate/Taurursodiol (Relyvrio) (PDF) | CP.PHAR.584 | July 1, 2025 |
| Sodium thiosulfate (Pedmark) (PDF) | CP.PHAR.610 | April 1, 2025 |
| Sodium Zirconium Cyclosilicate (Lokelma) (PDF) | CP.PMN.163 | October 1, 2025 |
| Sofosbuvir-Velpatasvir (Epclusa) (PDF) | HIM.PA.SP1 | December 1, 2025 |
| Sofosbuvir (Sovaldi) (PDF) | HIM.PA.SP2 | December 1, 2025 |
| Sofosbuvir-Vepatasvir-Voxilaprevir (Vosevi) (PDF) | HIM.PA.SP63 | December 1, 2025 |
| Solriamfetol (Sunosi) (PDF) | CP.PMN.209 | September 1, 2025 |
| Sonidegib (Odomzo) (PDF) | CP.PHAR.272 | July 1, 2025 |
| Sorafenib (Nexavar) (PDF) | CP.PHAR.69 | September 1, 2025 |
| Sotatercept (ACE-011) (PDF) | CP.PHAR.657 | April 1, 2025 |
| Sotorasib (Lumakras) (PDF) | CP.PHAR.549 | October 1, 2025 |
| Sotorasib (Lumakras) (PDF) | CP.PHAR.549 | Version effective until October 1, 2025 |
| Sotrovimab (VIR-7831) (PDF) | CP.PHAR.541 | Pending FDA Approval |
| Sparsentan (Filspari) (PDF) | CP.PHAR.631 | October 1, 2025 |
| Spesolimab-sbzo (Spevigo) (PDF) | CP.PHAR.606 | October 1, 2025 |
| Spinosad (Natroba) (PDF) | HIM.PA.134 | September 1, 2024 |
| Step Therapy Criteria (PDF) | HIM.PA.109 | July 1, 2025 |
| Stiripentol (Diacomit) (PDF) | CP.PMN.184 | January 1, 2025 |
| Sunitinib (Sutent) (PDF) | CP.PHAR.73 | September 1, 2025 |
| Sunvozertinib (Zegfrovy) (PDF) | CP.PHAR.742 | October 1, 2025 |
| Sutimlimab-jome (Enjaymo) (PDF) | CP.PHAR.503 | July 1, 2025 |
| Suvorexant (Belsomra®) (PDF) | CP.PMN.109 | January 1, 2025 |
| Suzetrigine (Journavx) (PDF) | CP.PMN.301 | October 1, 2025 |
| Tadalafil (Adcirca®) (PDF) | CP.PHAR.198 | April 1, 2025 |
| Tadalafil BHP - ED (Cialis) (PDF) | CP.PMN.132 | October 1, 2025 |
| Tafamidis (Vyndaqel, Vyndamax) (PDF) | CP.PHAR.432 | October 1, 2025 |
| Tafasitamab-cxix (Monjuvi) (PDF) | CP.PHAR.508 | October 1, 2025 |
| Talquetamab-tgvs (Talvey) (PDF) | CP.PHAR.649 | March 1, 2025 |
| Talazoparib (Talzenna) (PDF) | CP.PHAR.409 | April 1, 2025 |
| Taletrectinib (Ibtrozi) (PDF) | CP.PHAR.741 | October 1, 2025 |
| Taliglucerase Alfa (Elelyso) (PDF) | CP.PHAR.157 | October 1, 2025 |
| Talimogene laherparepvec (Imlygic) (PDF) | CP.PHAR.542 | October 1, 2025 |
| Tapinarof (Vtama) (PDF) | CP.PMN.283 | April 1, 2025 |
| Tarlatamab-dlle (Imdelltra) (PDF) | CP.PHAR.685 | October 1, 2025 |
| Tasimelteon (Hetlioz) (PDF) | CP.PMN.104 | April 1, 2025 |
| Tavaborole (Kerydin®) (PDF) | CP.PMN.105 | April 1, 2025 |
| Tazarotene (Arazlo, Fabior, Tazorac) (PDF) | CP.PMN.244 | March 1, 2025 |
| Tazemetostat (PDF) | CP.PHAR.452 | April 1, 2025 |
| Tebentafusp-tebn (Kimmtrak) (PDF) | CP.PHAR.575 | July 1, 2025 |
| Teclistamab-cqyv (Tecvayli) (PDF) | CP.PHAR.611 | April 1, 2025 |
| Tedizolid (Sivextro) (PDF) | CP.PMN.62 | October 1, 2025 |
| Teduglutide (Gattex) (PDF) | CP.PHAR.114 | April 1, 2025 |
| Telisotuzumab Vedotin-tllv (Emrelis) (PDF) | CP.PHAR.733 | October 1, 2025 |
| Telotristat ethyl (Xermelo) (PDF) | CP.PHAR.337 | October 1, 2025 |
| Temozolomide (Temodar) (PDF) | CP.PHAR.77 | September 1, 2025 |
| Temsirolimus (Torisel®) (PDF) | CP.PHAR.324 | January 1, 2025 |
| Tenapanor (Ibsrela, Xphozah) (PDF) | HIM.PA.174 | July 1, 2025 |
| Tenapanor (Ibsrela, Xphozah) | CP.PMN.224 | October 1, 2025 |
| Tenofovir Alafenamide Fumarate (Vemlidy) (PDF) | CP.PMN.268 | October 1, 2025 |
| Teplizumab (PDF) | CP.PHAR.492 | April 1, 2025 |
| Tepotinib (Tepmetko) (PDF) | CP.PHAR.530 | July 1, 2025 |
| Teprotumumab (Tepezza) (PDF) | CP.PHAR.465 | April 1, 2025 |
| Teriflunomide (Aubagio) (PDF) | CP.PCH.40 | July 1, 2025 |
| Teriparatide (Forteo®) (PDF) | CP.PHAR.188 | October 1, 2025 |
| Tesamorelin (Egrifta) (PDF) | CP.PHAR.109 | October 1, 2025 |
| Testosterone (Androderm) (PDF) | HIM.PA.87 | June 1, 2025 |
| Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) (PDF) | CP.PHAR.354 | June 1, 2025 |
| Tetrabenazine (Xenazine) (PDF) | CP.PHAR.92 | July 1, 2025 |
| Tezacaftor-Ivacaftor (Symdeko) (PDF) | CP.PHAR.377 | December 1, 2025 |
| Tezepelumab (Tezspire) (PDF) | CP.PHAR.576 | February 1, 2024 |
| Thalidomide (Thalomid) (PDF) | CP.PHAR.78 | October 1, 2025 |
| Thioguanine (Tabloid) (PDF) | CP.PHAR.437 | March 1, 2025 |
| Thyrotropin Alfa (Thyrogen) (PDF) | CP.PHAR.95 | October 1, 2025 |
| Timothy grass pollen allergen extract (Grastek®) (PDF) | CP.PMN.84 | October 1, 2025 |
| Tiopronin Delayed-Release (Thiola EC) (PDF) | CP.PCH.50 | July 1, 2025 |
| Tiopronin Delayed-Release (Thiola EC) (PDF) | CP.PHAR.725 | July 1, 2025 |
| Tirzepatide (Zepbound) (PDF) | CP.PMN.298 | October 1, 2025 |
| Tisagenlecleucel (Kymriah) (PDF) | CP.PHAR.361 | June 1, 2025 |
| Tislelizumab-jsgr (Tevimbra) (PDF) | CP.PHAR.687 | October 1, 2025 |
| Tisotumab Vedotin-tftv (Tivdak) | CP.PHAR.561 | March 1, 2025 |
| Tivozanib (Fotivda) (PDF) | CP.PHAR.538 | July 1, 2025 |
| Tixagevimab-Cilgavimab (Evusheld) (PDF) | CP.PHAR.571 | July 1, 2023 |
| Tobramycin (PDF) | CP.PHAR.211 | October 1, 2025 |
Tocilizumab
(Actemra), Tocilizumab-bavi (Tofidence), Tocilizumab-aazg (Tyenne)(PDF) | CP.PHAR.263 | January 1, 2025 |
| Tofersen (Qalsody) (PDF) | CP.PHAR.591 | January 1, 2025
|
| Tolvaptan (Jynarque) (PDF) | CP.PHAR.27 | December 1, 2025 |
| Topotecan (Hycamtin) (PDF) | CP.PHAR.64 | July 1, 2025 |
| Topical Acne Treatment (PDF) | HIM.PA.71 | January 1, 2025 |
| Topical Immunomodulators (PDF) | CP.PMN.107 | April 1, 2025 |
| Topiramate ER (Qudexy XR, Trokendi XR (PDF) | CP.PMN.281 | October 1, 2025 |
| Toripalimab-tpzi (Loqtorzi) (PDF) | CP.PHAR.668 | April 1, 2025 |
| Tovorafenib (Ojemda) (PDF) | CP.PHAR.686 | October 1, 2025 |
| Trabectedin (Yondelis) (PDF) | CP.PHAR.204 | April 1, 2025 |
| Tralokinumab-ldrm (Adbry) (PDF) | CP.PHAR.577 | July 1, 2025 |
| Trametinib (Mekinist) (PDF) | CP.PHAR.240 | July 1, 2025 |
| Trastuzumab Biosimilars Trastuzumab-Hyaluronidase (PDF) | CP.PHAR.228 | August 1, 2025
|
| Travoprost (iDose TR) (PDF) | CP.PHAR.672 | April 1, 2025 |
| Tremelimumab-actl (Imjudo) (PDF) | CP.PHAR.612 | June 1, 2025 |
| Tremelimumab-actl (Imjudo) (PDF) | CP.PHAR.612 | June 1, 2025 |
| Treprostinil (Orenitram, Remodulin, Tyvaso, Yutrepia) (PDF) | CP.PHAR.199 | August 1, 2025 |
| Triamcinolone ER Injection (Zilretta) (PDF) | CP.PHAR.371 | June 1, 2025 |
| Triclabendazole (Egaten) (PDF) | CP.PMN.207 | October 1, 2025 |
| Trientine (Syprine) (PDF) | CP.PHAR.438 | January 1, 2025 |
| Trifarotene (Aklief) (PDF) | CP.PMN.225 | April 1, 2025 |
| Trifluridine/Tipiracil (Lonsurf) (PDF) | CP.PHAR.383 | October 1, 2025 |
| Triheptanoin (Dojolvi) ^ (PDF) | CP.PHAR.509 | January 1, 2025 |
| Triptorelin pamoate (Trelstar®, Triptodur®) (PDF) | CP.PHAR.175 | June 1, 2025 |
| Trofinetide (Daybue) (PDF) | CP.PHAR.600 | July 1, 2025 |
| Tucatinib (Tukysa) (PDF) | CP.PHAR.497 | October 1, 2025 |
| Ublituximab-xiiy (Briumvi) (PDF) | CP.PHAR.621 | October 1, 2025 |
| Udenafil (PDF) | CP.PHAR.557 | December 1, 2023 |
| Ulcer Therapy Combinations (Omeclamox Pak, Pylera, Talicia)(PDF) | CP.PMN.277 | October 1, 2025 |
| Umbralisib (Ukoniq) (PDF) | CP.PHAR.531 | July 1, 2025 |
| Uridine acetate (Vistogard) (PDF) | HIM.PA.SP55 | January 1, 2025 |
| Vadadustat (Vafseo) (PDF) | CP.PHAR.677 | September 1, 2025
|
| Valbenazine (Ingrezza, Ingrezza Sprinkle) (PDF) | CP.PCH.48 | July 1, 2025 |
| valganciclovir (Valcyte) (PDF) | CP.PCH.06 | April 1, 2025 |
| Valoctocogene Roxaparvovec (PDF) | CP.PHAR.466 | May 1, 2025 |
| Valrubicin (Valstar) (PDF) | CP.PHAR.439 | March 1, 2025 |
| Vamorolone (Agamree) (PDF) | CP.PHAR.659 | April 1, 2025 |
| Vandetanib (Caprelsa®) (PDF) | CP.PHAR.80 | April 1, 2025 |
| Vanzacaftor/Tezacaftor/Deutivacaftor (Alyftrek) (PDF) | CP.PHAR.700 | October 1, 2025 |
| Varenicline (Tyrvaya) (PDF) | CP.PMN.273 | April 1, 2025 |
| Velaglucerase Alfa (VPRIV) (PDF) | CP.PHAR.163 | October 1, 2025 |
| Velmanase Alfa-tycv (Lamzede) (PDF) | CP.PHAR.601 | July 1, 2025 |
| Vemurafenib (Zelboraf®) (PDF) | CP.PHAR.91 | June 1, 2025 |
| Venetoclax (Venclexta) (PDF) | CP.PHAR.129 | January 1, 2025 |
| Vestronidase alfa-vjbk (Mepsevii) (PDF) | CP.PHAR.374 | July 1, 2025 |
| Verteporfin (PDF) | CP.PHAR.187 | April 1, 2025 |
| Vigabatrin (Sabril) (PDF) | CP.PHAR.169 | September 1, 2024 |
| Viloxazine (Qelbree) (PDF) | CP.PMN.264 | July 1, 2025 |
| Viltolarsen (Viltepso) (PDF) | CP.PHAR.484 | April 1, 2025 |
| Vimseltinib (Romvimza) (PDF) | CP.PHAR.726 | July 1, 2025 |
| Vismodegib (Erivedge) (PDF) | CP.PHAR.273 | July 1, 2025 |
| Vutrisiran (Amvuttra) | CP.PHAR.550 | July 1, 2025 |
| Voclosporin (Lupkynis) (PDF) | CP.PHAR.504 | July 1, 2025 |
| Vorapaxar (Zontivity) (PDF) | HIM.PA.146 | April 1, 2025 |
| Vorasidenib (Voranigo) (PDF) | CP.PHAR.699 | July 1, 2025 |
| Voretigene neparvovec-rzyl (Luxturna) (PDF) | CP.PHAR.372 | April 1, 2025 |
| Vorinostat (Zolinza) (PDF) | CP.PHAR.83 | October 1, 2025 |
| Vortioxetine (Trintellix®) (PDF) | CP.PMN.65 | October 1, 2025 |
| Vosoritide (Voxzogo) (PDF) | CP.PHAR.525 | April 1, 2025 |
| Voxelotor (Oxbryta) (PDF) | CP.PHAR.451 | April 1, 2025 |
| Xanomeline-trospium chloride (Cobenfy) (PDF) | CP.PMN.299 | April 1, 2025 |
| Zanidatamab-hrii (Ziihera) (PDF) | CP.PHAR.709 | August 1, 2025 |
| Zanubrutinib (Brukinsa) (PDF) | CP.PHAR.467 | October 1, 2025 |
| Zavegepant (Zavzpret) (PDF) | CP.PHAR.630 | March 1, 2025 |
| Zenocutuzumab-zbco (Bizengri) (PDF) | CP.PHAR.713 | August 1, 2025 |
| Zilucoplan (RA101495) (PDF) | CP.PHAR.616 | June 1, 2025 |
| Ziv-aflibercept (Zaltrap®) (PDF) | CP.PHAR.325 | January 1, 2025 |
| Zolbetuximab-clzb (Vyloy) (PDF) | CP.PHAR.705 | August 1, 2025 |
| Zoledronic acid (PDF) | CP.PHAR.59 | June 1, 2025 |
| Zuranolone (Zurzuvae) (PDF) | CP.PHAR.650 | July 1, 2025 |